|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment charges on real estate | |||||
| Equity in income of unconsolidated entity | |||||
| Distribution of operating cash flow from unconsolidated entity | |||||
| Deferred rents | |||||
| Amortization of above- and below-market leases, net | |||||
| Amortization of deferred financing costs | |||||
| Unrealized losses on derivative instruments | |||||
| Gain related to swap terminations | |||||
| Interest rate swap settlement for early terminated swaps | |||||
| Gain from extinguishment of debt | |||||
| Gain on sale of real estate | |||||
| Write-off of prepaid offering costs | |||||
| Interest rate swap settlements for off-market swap instruments | |||||
| Changes in operating assets and liabilities: | |||||
| Rents and other receivables | |||||
| Due from affiliates | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Due to affiliates | |||||
| Other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Improvements to real estate | |||||
| Proceeds from sale of real estate, net | |||||
| Proceeds from the sale of real estate equity securities | |||||
| Purchase of interest rate cap | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from notes payable | |||||
| Principal payments on notes payable | |||||
| Payments of deferred financing costs | |||||
| Interest rate swap settlements for off-market swap instruments | |||||
| Restricted cash surrendered from deed-in-lieu of foreclosure | |||||
| Payments to redeem common stock | |||||
| Payments of prepaid other offering costs | |||||
| Payments of other offering costs | |||||
| Distributions paid to common stockholders | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Interest paid | |||||
| Supplemental Disclosure of Noncash Investing and Financing Activities: | |||||
| Distributions payable | |||||
| Mortgage loan extinguished in connection with deed-in-lieu of foreclosure | |||||
| Real estate transferred in connection with deed-in-lieu of foreclosure | |||||
| Net liabilities transferred in connection with deed-in-lieu of foreclosure | |||||
| Distributions paid to common stockholders through common stock issuances pursuant to the dividend reinvestment plan | |||||
| Redeemable common stock payable | |||||
| Accrued improvements to real estate | |||||
| Accrued prepaid other offering costs | |||||
| Accrued deferred loan financing costs | |||||
| Accrued disposition fees | |||||
| Accrued interest rate swap settlements related to off-market swap instruments | |||||
| Real estate equity securities reclassed from investment in unconsolidated entity | |||||
Loading...